Activity Monitoring in Pulmonary Hypertension
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Pulmonary Hypertension
- Type
- Observational
- Design
- Observational Model: Case-OnlyTime Perspective: Prospective
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
A prospective, longitudinal, observational study of free-living activity tracking and patient-reported outcomes in participants enrolled in the Longitudinal Pulmonary Vascular Disease Phenomics Program (L-PVDOMICS). Participants will undergo activity monitoring for 12 weeks once a year for 4 years. ...
A prospective, longitudinal, observational study of free-living activity tracking and patient-reported outcomes in participants enrolled in the Longitudinal Pulmonary Vascular Disease Phenomics Program (L-PVDOMICS). Participants will undergo activity monitoring for 12 weeks once a year for 4 years. Patient-reported outcomes will be collected including quality of life (emphasis-10, Minnesota Living with Heart Failure (MLHF), and SF-36 surveys), medication changes, hospitalization, and death. This study aims to enroll 500 participants. The objectives of this study are to establish the clinical utility of daily activity tracking in patients with pulmonary hypertension and to identify clinical factors associated with reduced daily activity.
Tracking Information
- NCT #
- NCT04101630
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Evan L Brittain, MD Vanderbilt University Medical Center
Get Well Soon